Schweihofer, V., Bruss, C., Seitz, S., Glehr, G., Hetterich, M., Weber, F., . . . Wege, A. K. Breast cancer scoring based on a multiplexed profiling of soluble and cell-associated (immune) markers facilitates the prediction of pembrolizumab therapy. BMC.
Chicago Style (17th ed.) CitationSchweihofer, Verena, et al. Breast Cancer Scoring Based on a Multiplexed Profiling of Soluble and Cell-associated (immune) Markers Facilitates the Prediction of Pembrolizumab Therapy. BMC.
MLA (9th ed.) CitationSchweihofer, Verena, et al. Breast Cancer Scoring Based on a Multiplexed Profiling of Soluble and Cell-associated (immune) Markers Facilitates the Prediction of Pembrolizumab Therapy. BMC.
Warning: These citations may not always be 100% accurate.